ChatGPT for Medical Dosimetrists: 26 AI Prompts That Save Hours on Treatment Plan Docs, Peer Review Prep & CMD Exam Study

Write a radiation treatment plan summary note in formal radiation oncology clinical language. Patient: [age]-year-old [sex], diagnosis: [cancer type/site — e.g., prostate adenocarcinoma, left breast IDC, right upper lobe NSCLC].

ICD-10: [e.g., C61 prostate / C50.912 breast / C34.11 lung — specify].
Technique: [VMAT/IMRT/3D-CRT/SBRT/SRS — specify]. Delivery: [linac model, energy, MLC system].
Prescription: [dose per fraction] Gy × [number of fractions] = [total dose] Gy to [target volume — PTV_primary / PTV_boost]; isodose line: [X%]; normalization: [X%].
Target volumes (TPS): GTV = [X cc], CTV = [X cc], PTV = [X cc], margin expansion: [X mm isotropic/asymmetric — specify].

OAR constraints met:
- [OAR 1 — e.g., rectum V75 <15%, V70 <20%, V65 <25% — achieved: Y/N, actual value]
- [OAR 2 — e.g., bladder V80 <15% — achieved: Y/N, actual value]
- [OAR 3 — specify per site]

DVH summary: PTV coverage [D95 = X Gy, D98 = X Gy, Dmean = X Gy, CI = X, HI = X].
Plan approved by: [radiation oncologist name/credentials], [medical physicist name/credentials].
Write a concise 2-paragraph summary note: (1) technique, prescription, target coverage; (2) OAR constraints with achieved values, plan approval. De-identified. Radiation oncology standard format.

Write a treatment plan peer review documentation note per ASTRO Radiation Oncology Incident Learning System (RO-ILS) and ACR/ASTRO peer review standards.

Patient: [age]-year-old [sex], site: [diagnosis/stage]. Technique: [IMRT/VMAT/SBRT — specify].
Reviewer: [radiation oncologist reviewer name/credentials], Date: [review date], Setting: [weekly chart rounds / pre-treatment review / prospective peer review — specify].

Peer review documentation:
(1) Plan reviewed: prescription, dose/fractionation, target volumes reviewed — [consistent with diagnosis and NCCN guidelines / deviations noted — specify].
(2) OAR constraints reviewed: [met per QUANTEC/RTOG protocol constraints / specific deviation with clinical justification — specify].
(3) Target volume contours: [appropriate / discrepancy noted — specify].
(4) Imaging review: [simulation CT/MRI/PET fusion reviewed; appropriate margins confirmed / modification requested — specify].
(5) Recommendations: [approve as submitted / modifications required — specify changes; timeline for re-review if applicable].
(6) Outcome: [plan approved / revised per recommendations].
ASTRO peer review standards. De-identified.

Write a physician prescription clarification note for the radiation oncology medical record. Purpose: document a verbal or written order clarification between the dosimetrist and the prescribing radiation oncologist.

Clarification request:
(1) Date and method: [date, phone call / in-person / via EMR message — specify].
(2) Original prescription as written: [quote exact prescription — dose, fractionation, technique, field design, or constraint as originally documented].
(3) Ambiguity or discrepancy identified: [describe the specific question — e.g., prescription dose to PTV vs. GTV unclear; OAR constraint table referenced wrong protocol version; bilateral vs. unilateral field design not specified].
(4) Radiation oncologist response: [exact clarification provided by [Dr. Name, credentials] — quote or closely paraphrase].
(5) Action taken: [plan modified per clarification / plan confirmed as originally designed — specify].
(6) Documentation: [updated prescription order confirmed in EMR; dosimetrist and physician signatures/date required per institutional policy].
Formal medical record language. De-identified.

Write a physics consult note documenting a dosimetrist-to-physicist consultation during treatment planning. Patient: [age]-year-old [sex], site: [diagnosis]. Technique: [IMRT/VMAT/SBRT/SRS — specify].

Consult format:
(1) Reason for consultation: [specific planning challenge — e.g., proximity of PTV to spinal cord in H&N IMRT; SBRT lung plan requiring heterogeneity correction verification; electron field edge calculation needed for chest wall boost — specify].
(2) Dosimetrist question: [specific technical or clinical question posed to physicist — e.g., recommended planning margin for breathing motion on 4D-CT; appropriate MU calculation method for non-coplanar SRS arc; TLD/MOSFET in-vivo dosimetry requirement for pregnant patient].
(3) Physicist recommendation: [name, credentials, date]: [detailed answer — treatment planning approach, algorithm selection, special measurement requirement, or protocol reference — specify].
(4) Action taken: [plan revised per recommendation / independent MU check scheduled / special in-vivo dosimetry ordered — specify].
(5) Documentation: [physics consultation logged in TPS and EMR per institutional QA policy].
Formal radiation oncology documentation language. De-identified.

Write a treatment plan change/revision memo for the radiation oncology medical record. Patient: [age]-year-old [sex], site: [diagnosis], currently on treatment [fraction X of Y].

Revision memo:
(1) Reason for revision: [clinical indication — e.g., on-treatment imaging shows tumor regression requiring adaptive replanning; acute toxicity — esophagitis Grade 3 requiring OAR constraint modification; physician order change — boost field added; patient anatomy change requiring re-simulation — specify].
(2) Original plan summary: [original prescription, technique, OAR constraints as initially approved].
(3) Revision details: [specific changes made — new dose/fractionation, modified target volumes, updated OAR constraints, new plan name/version in TPS — specify].
(4) Dose accumulation/prior dose accounting: [cumulative dose to OARs calculated; biologically equivalent dose (BED) or equivalent dose in 2 Gy fractions (EQD2) considered if applicable — specify].
(5) Approvals: [revised plan approved by radiation oncologist [name] on [date]; physics secondary check completed by [name] on [date]].
(6) Patient/treatment team notification: [patient informed of replanning; radiation therapist team briefed — specify].
Formal radiation oncology medical record language. De-identified.

Write a radiation oncology QA incident or near-miss report per ASTRO RO-ILS reporting standards and TJC Sentinel Event requirements.

Report format:
(1) Event type: [incident — treatment delivered / near-miss — caught before delivery / sentinel event — specify].
(2) Event description: [date, time, location; factual description of what occurred or was discovered — e.g., incorrect treatment field size delivered for 1 fraction; wrong isocenter shift applied; MLC leaf pattern mismatch identified on pre-treatment EPID review — describe factually, no speculation].
(3) Discovery: [identified by — dosimetrist / physicist / radiation therapist / physician; discovery method — pre-treatment EPID/portal image review / independent MU check / daily IGRT imaging discrepancy / patient complaint — specify].
(4) Immediate actions: [treatment suspended / fraction re-delivered / physician notified / patient informed — specify; timeline].
(5) Dosimetric impact: [estimated dose deviation if deliverable — physicist calculation; clinical significance assessed by radiation oncologist: [name]].
(6) Root cause analysis: [system-level cause — e.g., TPS software version discrepancy; protocol not followed for plan approval checklist; shift miscommunication — specify].
(7) Corrective actions: [protocol update / staff retraining / TPS workflow modification — specify; responsible party and timeline].
(8) RO-ILS submission: [yes/no; submission date; anonymous reporting confirmed].
ASTRO RO-ILS / TJC standards. De-identified.

Write a multidisciplinary tumor board (MDT) summary note for a radiation oncology case presentation. Patient: [age]-year-old [sex], diagnosis: [cancer type, stage per AJCC 8th edition — e.g., Stage IIIA NSCLC cT2bN2M0], referring service: [medical oncology / surgical oncology / pulmonology — specify].

Tumor board summary:
(1) Case presentation: [date, presenter name/credentials, patient diagnosis, staging workup summary — CT, PET-CT, MRI, pathology, molecular markers if applicable].
(2) Treatment history: [prior surgery / chemotherapy / immunotherapy — dates and details, or de novo presentation].
(3) Multidisciplinary discussion: [key clinical questions posed — resectability, optimal sequencing, radiation candidacy, systemic therapy integration — summarize discussion points by discipline].
(4) Consensus recommendation: [definitively recommended treatment approach — radiation technique (SBRT/IMRT/VMAT/proton), dose/fractionation, systemic therapy sequencing, supportive care; notation of minority opinion if present].
(5) Follow-up action items: [additional staging workup required / simulation scheduled / medical oncology consult pending — specify responsible party and timeline].
(6) Attending of record: [radiation oncologist name/credentials, tumor board chair].
MDT conference documentation format. AJCC 8th edition staging. De-identified.

Write a prior authorization letter for a complex radiation therapy technique. Patient: [age]-year-old [sex], diagnosis: [cancer type/ICD-10], payer: [commercial insurer / Medicare / Medicaid — specify plan name].

Technique requested: [SBRT — e.g., lung SBRT 54 Gy / 3 fx / VMAT / IMRT — specify and CPT codes: 77385/77386 IMRT; 77373 SBRT; 77371 SRS — specify].

Prior auth letter:
(1) Diagnosis and clinical indication: ICD-10 [code], stage [AJCC], clinical rationale for complex technique vs. conventional 3D-CRT.
(2) Medical necessity statement: [cite NCCN guideline recommendation, ASTRO appropriate use criteria, or published evidence base — e.g., RTOG 0236 for lung SBRT; NCCN Category 1 evidence for prostate IMRT — specify].
(3) Technical justification: complex anatomy requiring IMRT OAR sparing; motion management required for SBRT; dose escalation clinically indicated; heterogeneity correction required — [specify applicable rationale].
(4) Alternative considered: [conventional 3D-CRT not appropriate because — specify clinical reason].
(5) Requesting provider: [radiation oncologist name, NPI, practice address, fax].
(6) Supporting documentation attached: simulation note, physician prescription, NCCN guideline excerpt.
Formal insurance prior authorization letter format.

Write a patient education handout for a radiation therapy patient. Reading level: 6th grade. Warm, clear, reassuring tone. Suitable for print or patient portal.

Patient: [age]-year-old [sex], treatment: [site — e.g., prostate / breast / lung — specify], technique: [EBRT / SBRT — specify], schedule: [X fractions over X weeks / X fractions total].

Handout sections:
(1) Title: "Your Radiation Therapy Plan — What to Expect."
(2) Your treatment schedule: [X treatments, X days/week, approximately X minutes each visit including setup time; daily imaging explained simply — "we take a quick picture to make sure you are positioned correctly."]
(3) How radiation works: 2-3 simple sentences — targets cancer cells, normal cells nearby can be temporarily affected, your body repairs itself between treatments.
(4) Side effects to expect (site-specific):
   - [List 3-4 most common side effects for the specified site in plain language — e.g., for prostate: urinary frequency/urgency, bowel changes, fatigue]
   - When to call us: [specific warning signs — fever, severe pain, blood in urine/stool, sudden worsening — specify by site]
(5) Taking care of yourself: rest, nutrition, skin care (avoid lotions on treatment area unless approved), hydration.
(6) Questions to ask your care team: 3 suggested questions.
(7) Contact info: [clinic name, phone number, after-hours line]. De-identified template.

Create an audit preparation checklist for a radiation oncology department preparing for an NRC materials license inspection or ACR radiation oncology accreditation survey.

Checklist format — organize by audit type:

NRC MATERIALS LICENSE INSPECTION (if applicable — HDR/LDR brachytherapy or therapy radiopharmaceuticals):
□ Radiation protection program current and posted
□ Authorized user and RSO credentials current; training documentation on file
□ Written directive and pre-treatment verification records for each patient
□ Source inventory and calibration records (within 30 days of use)
□ Quality management program (10 CFR 35.40) documented
□ Misadministration/recordable event log current; NRC reports filed if required
□ Emergency procedures posted and staff trained

ACR RADIATION ONCOLOGY ACCREDITATION:
□ Physician credentials and peer review documentation current
□ Physics staffing meets ACR standard (DABR certification)
□ TPS commissioning and annual QA documentation complete
□ Machine-specific QA records (daily/monthly/annual per TG-142)
□ Treatment plan peer review rate ≥90% (ACR standard)
□ Patient safety event log and near-miss reporting policy documented
□ Patient satisfaction data collected and reviewed
□ Facility diagram, shielding reports, and survey records on file

Add department-specific items as needed. Assign responsible staff member and completion date to each line item.

Write a radiation oncology incident learning system (ILS) report suitable for submission to ASTRO RO-ILS or an internal institutional safety reporting system.

ILS report format:
(1) Report type: [near-miss / incident — no patient harm / incident — patient harm / good catch — specify].
(2) Event summary (factual, non-attributive): [1-3 sentence description of what happened or was caught — e.g., during pre-treatment chart check, dosimetrist identified that the plan approved in TPS had a different isocenter coordinate than the shift instructions provided to the treatment team; discrepancy was 0.3 cm in lateral direction — specify].
(3) Process step where event occurred: [simulation / contouring / treatment planning / plan approval / treatment delivery / QA — specify].
(4) Contributing factors (check all that apply): □ Communication breakdown □ Distraction/interruption □ Software/hardware issue □ Protocol not followed □ Training gap □ Inadequate double-check system □ Other: [specify].
(5) Immediate corrective action taken: [specify what was done before this report was filed].
(6) Suggested system-level improvement: [process change, checklist addition, training, software fix — specify].
(7) Reporter role: [dosimetrist / physicist / radiation therapist / physician — do not include name for anonymous submission].
ASTRO RO-ILS reporting format. Non-punitive, system-focused language.

Write an accreditation documentation package entry for a radiation oncology department preparing for TJC (The Joint Commission) survey or ACR radiation oncology accreditation review.

Documentation entry type: [choose one — treatment plan peer review policy / QA program summary / staff competency verification / equipment QA log summary / patient safety event policy / specify].

Documentation format:
(1) Policy/procedure title: [e.g., "Radiation Therapy Treatment Plan Peer Review Policy"].
(2) Policy statement: [concise statement of intent — e.g., "All radiation therapy treatment plans are reviewed by a second radiation oncologist prior to treatment delivery in accordance with ASTRO and ACR peer review standards."].
(3) Scope: [who this applies to — all patients receiving external beam radiation therapy at [facility name]].
(4) Procedure steps: [numbered list of specific process steps — simulation, contouring, planning, peer review timing, documentation requirements].
(5) Compliance metric: [measurable standard — e.g., ≥90% of plans reviewed prior to fraction 3; 100% of SBRT/SRS plans reviewed prior to first fraction].
(6) Responsible parties: [radiation oncologist / medical physicist / dosimetrist / radiation therapist — specify role].
(7) Documentation: [how compliance is documented — EMR, TPS audit log, peer review database].
(8) Review cycle: [annual policy review; department director signature required].
TJC/ACR accreditation standards. Institutional policy format.

Create a domain-weighted study guide for the AAMD Certified Medical Dosimetrist (CMD) exam based on the official AAMD exam blueprint.

AAMD domain weights (approximate):
- Treatment Planning: ~40% (TPS algorithms, dose calculation, optimization, DVH analysis, plan evaluation, special techniques — SBRT/SRS/IMRT/VMAT)
- Clinical/Physics: ~30% (radiation physics, radiobiology, imaging, dosimetry equipment, QA)
- Patient Care: ~20% (patient safety, simulation, immobilization, image-guided RT, brachytherapy)
- Professional/Administrative: ~10% (ethics, regulatory, AAMD standards, scope of practice)

For each domain generate:
(1) 5 highest-yield facts
(2) 2 most common exam traps
(3) Recommended resource (Khan's Physics of Radiation Therapy; Washington & Leaver Principles & Practice of Radiation Therapy; AAMD study guide; AAPM TG reports — specify which)
(4) 3-item self-check quiz with answer key

Study schedule: Weeks 1-10: one domain per 2.5 weeks, heaviest time on Treatment Planning. Weeks 11-12: full practice test + weak-area targeting. Week 13: targeted review. Week 14: rest + final review.

Create 3 CMD exam-style practice questions (A-D format) with correct answer and rationale. Format: clinical vignette → question → 4 choices → answer + rationale + exam trap.

Q1 — DVH Objectives: [Prostate IMRT plan. PTV D95 = 74.8 Gy (prescription 76 Gy). Rectum V70 = 14%, V65 = 22%, V60 = 35%. Is this plan acceptable per QUANTEC constraints?] A) Yes — all constraints met; B) No — D95 underdoses PTV; C) No — V60 rectum exceeds limit; D) No — V65 rectum exceeds limit. Answer: B. Rationale: D95 = 74.8 Gy when prescription is 76 Gy = 98.4% coverage — typically acceptable; however, primary concern is PTV D95 must meet prescription per ICRU reporting. Rectum constraints shown are within QUANTEC limits (V70 <15%, V65 <25%, V60 <35%). Trap: Do not confuse D95 absolute dose with coverage percentage — D95 should equal prescription dose ±5%.

Q2 — OAR Constraints: [Lung SBRT 54 Gy/3 fx. Spinal cord Dmax = 21.9 Gy. Is this acceptable?] A) No — exceeds PRV limit; B) Yes — within RTOG 0236 cord constraint; C) No — BED10 exceeds 50 Gy; D) Cannot determine without fractionation correction. Answer: B. Rationale: RTOG 0236 spinal cord Dmax ≤21.9 Gy (3 fx) — exactly at constraint limit, technically met. Trap: confusing cord Dmax with PRV constraint (PRV cord Dmax may be different per protocol).

Q3 — ICRU Reporting: [Which ICRU report establishes the standard for dose prescription and reporting for IMRT?] A) ICRU 50; B) ICRU 62; C) ICRU 83; D) ICRU 91. Answer: C. Rationale: ICRU Report 83 specifically addresses prescribing, recording, and reporting of IMRT. ICRU 50/62 = 3D-CRT; ICRU 91 = SRS/SBRT. Trap: knowing which ICRU applies to which technique.

Create 3 CMD exam-style clinical physics questions with rationale. Format: clinical vignette → question → 4 choices → answer + rationale + exam trap.

Q1 — MU Calculation Verification: [A 6 MV photon beam, 100 cm SSD, 10×10 cm field, prescribed dose 200 cGy to Dmax. TMR = 1.000. Output factor = 1.000. What is the expected MU?] A) 100 MU; B) 150 MU; C) 200 MU; D) 250 MU. Answer: C — 200 MU. Rationale: MU = D / (TMR × OF × Output) = 200 / (1.000 × 1.000 × 1.000) = 200 MU. At reference conditions (10×10, 100 SSD, Dmax), output = 1 cGy/MU. Trap: Remember output factor and TMR are both 1.0 only at reference conditions — vary field size or depth and these change.

Q2 — TPS Commissioning: [Which measurement dataset is required to commission an IMRT TPS per AAPM TG-119?] A) PDD and TMR only; B) Output factors, PDD, TMR, and off-axis profiles; C) Small field output factors only; D) MLC transmission and penumbra measurements only. Answer: B. Rationale: TG-119 TPS commissioning requires comprehensive beam data — output factors (all clinically used field sizes), PDDs, TMRs, and off-axis profiles for accurate dose calculation. MLC transmission is separate (TG-142 machine QA). Trap: TG-119 is for IMRT commissioning specifically; TG-142 covers machine QA.

Q3 — IGRT Protocols: [A patient with prostate cancer is treated with daily CBCT-guided IGRT. The CBCT shows a 5 mm posterior shift. According to standard IGRT action thresholds, what should occur?] A) Treat — within tolerance; B) Apply shift and treat; C) Notify physicist and do not treat; D) Repeat simulation. Answer: B. Rationale: 5 mm shift is within typical action level (>3 mm trigger for correction, <10 mm proceed after correction). Apply shift, verify, treat. Trap: Do not confuse action threshold (when to correct) with tolerance (when to stop and notify) — institutions vary; know your protocol values.

Create an evidence-based practice quick-reference for radiation oncology dose constraints used in CMD practice.

QUANTEC OAR CONSTRAINTS (most tested on CMD exam):
- Spinal cord: Dmax ≤45 Gy (conventional fx); risk <0.2% myelopathy
- Brainstem: Dmax ≤54 Gy; Dmax ≤60 Gy if small volume (<1-2 cc)
- Optic chiasm/nerves: Dmax ≤55 Gy; risk <3% optic neuropathy
- Parotid glands: Mean ≤25 Gy (one gland) or mean ≤20 Gy (bilateral); risk <20% xerostomia
- Lung: V20 ≤30-35% (both lungs combined); Mean lung dose ≤20-23 Gy; risk <20% Grade 2+ pneumonitis
- Heart: V25 ≤10%; Mean ≤26 Gy (varies by site/protocol)
- Rectum (prostate EBRT): V70 <15%, V65 <25%, V60 <35%
- Liver: Mean ≤30-32 Gy (normal liver); V30 <60%

RTOG/NRG SBRT CONSTRAINTS (selected, verify current protocol):
- Lung SBRT (RTOG 0236, 54 Gy/3 fx): Spinal cord Dmax ≤21.9 Gy; esophagus Dmax ≤27.5 Gy; heart Dmax ≤30 Gy; great vessels Dmax ≤45 Gy
- Spine SBRT: Spinal cord 0.035 cc ≤14 Gy per fraction (varies by fractionation)

KEY EXAM PRINCIPLE: QUANTEC = population-based TD5/5 and TD50/5 data; always verify against current institutional protocol or active clinical trial constraints — these supersede QUANTEC.

Create a 24-contact-hour CMD recertification continuing education plan for the 5-year recertification cycle. AAMD requires 24 hours of approved CE over 5 years; minimum 2 hours ethics; all activities from AAMD-approved providers or qualifying categories.

5-Year CMD CE Plan — 24 Hours Total:

Year 1 — 6 hours:
- AAMD Annual Meeting sessions (treatment planning optimization, new techniques) — 3 hours
- AAMD-approved online module: IGRT advances and adaptive radiation therapy — 1.5 hours
- Ethics (required): AAMD Code of Ethics; radiation oncology scope of practice — 1.5 hours

Year 2 — 5 hours:
- ASTRO Annual Meeting dosimetry-relevant sessions — 2 hours
- Vendor/manufacturer CE webinar (TPS software update; proton therapy dosimetry) — 2 hours
- AAPM TG report self-study (TG-119, TG-142, or TG-218) — 1 hour

Year 3 — 5 hours:
- AAMD online CE library (dose calculation algorithms; Monte Carlo) — 3 hours
- Institutional in-service: QA protocol update or new equipment commissioning — 2 hours

Year 4 — 4 hours:
- AAMD conference or regional dosimetry society meeting — 4 hours

Year 5 — 4 hours:
- CMD exam review course or board prep content (if available) — 2 hours
- Journal club / case review self-study (IJROBP, Practical Radiation Oncology) — 2 hours

Set calendar alerts at 6 months and 1 year before recertification deadline. Log all CE in AAMD recertification portal immediately upon completion.

Generate a mock oral board Q&A session for CMD exam preparation. Format: examiner question → ideal answer structure → key points to hit → common pitfalls.

Q1 — Treatment Planning: "Walk me through how you would evaluate a prostate IMRT plan for clinical acceptability."
Ideal answer structure: (1) PTV coverage — D95 ≥ prescription dose, D2 not exceeding 107% (ICRU 83); (2) OAR constraints — rectum V70/V65/V60 per QUANTEC; bladder V80/V70; (3) DVH review — dose gradient, CI, HI; (4) MU reasonableness check; (5) plan compared to prior plans for consistency.
Key points: reference ICRU 83, QUANTEC, and institutional protocol. Pitfall: failing to discuss both coverage AND normal tissue simultaneously.

Q2 — Clinical Physics: "What is the significance of the penumbra region in radiation therapy planning?"
Ideal answer: penumbra = dose gradient region at field edge; defined as distance between 80% and 20% isodose lines; larger penumbra → dose spillage to OARs; smaller penumbra preferred for targets near critical structures; affected by energy (higher energy = wider penumbra), source size, and distance.
Key points: know penumbra definition quantitatively. Pitfall: confusing physical penumbra with geometric penumbra.

Q3 — Professional: "A radiation oncologist asks you to start planning a patient before the prescription is signed. How do you respond?"
Ideal answer: (1) acknowledge the clinical urgency; (2) explain that a signed, written directive is required before treatment planning can begin per NRC regulations (10 CFR 35) and institutional policy; (3) offer to begin simulation preparation, contour import, or non-prescriptive setup work while awaiting the signed prescription.
Key point: cite regulatory requirement without being confrontational. Pitfall: saying "I would just start the plan" — this is a compliance violation.

Write an annual CMD clinical self-evaluation with SMART performance goals. Dosimetrist: [name, CMD credentials, years in role, institution, specialization — prostate/H&N/SBRT/pediatric — specify].

Self-evaluation format:
(1) Clinical volume: [X treatment plans/month; X SBRT/SRS plans/year; X adaptive/replanning cases/year; X brachytherapy plans/year if applicable].
(2) Current performance vs. benchmarks:
   - Plan quality metrics: [OAR constraint compliance rate X% / peer review modification rate X%]
   - Turnaround time: [median days sim-to-first-treatment X days vs. department target]
   - QA incident/near-miss rate: [X events/year; contribution to ILS submissions]
(3) SMART goals for next 12 months:
   - Goal 1: Complete [specific advanced technique — e.g., proton therapy planning training / MR-guided RT module] by [date]; apply to [X] cases.
   - Goal 2: Reduce plan revision rate from X% to <Y% by implementing standardized plan evaluation checklist by [date].
   - Goal 3: Submit [X] ILS good-catch reports to department safety database by year-end.
(4) Professional development: CMD CE plan progress; AAMD Annual Meeting attendance; advanced certification under consideration (e.g., proton dosimetry, brachytherapy).

Write a formal equipment downtime and treatment interruption incident report for a radiation oncology department. Event: [linac mechanical failure / TPS software outage / IGRT system failure / brachytherapy afterloader malfunction — specify].

Incident report:
(1) Event description: [date, time, machine/system ID; factual description of failure — error code, observable symptom, nature of interruption; fractions affected: X patients × Y fractions delayed/missed].
(2) Patient impact: [no dosimetric impact / treatment delay X hours/days; specific patients notified: yes/no; clinical significance assessed by radiation oncologist [name] — specify].
(3) Immediate actions: [treatment rescheduled; biomedical/vendor notified; backup linac utilized; patients contacted — specify timeline].
(4) Root cause: [preventive maintenance compliance / component failure outside PM schedule / software update conflict — specify].
(5) Corrective actions: [repair completed by [date]; PM schedule updated; staff notified; policy reviewed — specify].
(6) Regulatory reporting: [NRC report required if brachytherapy source involved — assess and document; ACR accreditation documentation updated; TJC incident log entry if patient safety event — specify].
Formal equipment downtime / patient safety documentation language. De-identified.

Write a PDSA quality improvement proposal for a radiation oncology dosimetry workflow. Choose: [Option A — peer review turnaround time / Option B — plan complexity scoring implementation — specify].

PDSA — OPTION A: Peer Review Turnaround Time
PLAN: Problem: median time from plan completion to peer review sign-off at [institution] is X days — target is ≤2 business days per ACR/ASTRO peer review standards. Root causes: [physician schedule variability / no escalation pathway for plans pending >48 hours / no EMR dashboard visibility — specify]. Intervention: automated EMR alert at 48 hours; dosimetrist-to-physician escalation pathway documented; weekly pending-review dashboard added to departmental huddle.
Metric: % of plans peer-reviewed within 2 business days; target ≥90%.
DO: Pilot 3 months; track all cases.
STUDY: Compare pre/post review turnaround; identify persistent delays by provider or case type.
ACT: Standardize alert system if target met; adjust escalation pathway if bottleneck persists.

PDSA — OPTION B: Plan Complexity Scoring
PLAN: Implement a standardized plan complexity scoring tool (e.g., Modulation Index, MCS, or institutional rubric) to identify plans requiring enhanced physics review. Define complexity thresholds; integrate into plan approval workflow.
Metric: % of high-complexity plans receiving enhanced physics review; reduction in high-complexity plan MU delivery errors.

Write an internal scope-of-practice memo and task matrix clarifying the roles of the medical dosimetrist (CMD), medical physicist (DABR/CAMPEP), and radiation therapist (RTT/ARRT) in a radiation oncology department. Audience: new staff, administrative leadership, referring physicians.

Sections:
(1) Medical Dosimetrist (CMD): treatment plan design and optimization in TPS; dose calculation; target volume and OAR contour review; DVH analysis; treatment planning documentation; physics consultation for complex plans; peer review preparation; brachytherapy planning (where credentialed). Requires: CMD credential (AAMD), institutional credentialing. Scope does NOT include: patient treatment delivery; radiation source handling without additional credentialing; final plan approval (physicist/physician sign-off required).

(2) Medical Physicist (DABR/CAMPEP-accredited): machine commissioning, QA, and calibration (TG-51, TG-142); independent MU verification; TPS commissioning; brachytherapy source calibration; special physics consultation; radiation safety program oversight (RSO). Final plan approval authority. Scope does NOT include: routine treatment planning (dosimetrist role) or patient setup/delivery.

(3) Radiation Therapist (RTT/ARRT-T): daily patient setup, immobilization, and treatment delivery per approved plan; IGRT image acquisition and review per shift instructions; daily machine QA (TG-142 daily checks); patient monitoring during treatment.

(4) Referral/task matrix table: Task | Primary Responsible | Secondary/Oversight | Documentation Required. Rows: treatment plan design, MU verification, plan approval, daily QA, IGRT review, patient education, incident reporting.

Write two cover letter versions for a CMD applying to radiation oncology dosimetry positions. My details: [paste CMD credential date, years of experience, clinical specializations — SBRT/proton/H&N/GYN brachytherapy, TPS proficiency (Eclipse/RayStation/Pinnacle), notable achievements, publications or QI work if applicable].

Version A — Academic / Comprehensive Cancer Center:
Emphasize: advanced technique volume (SBRT/SRS case counts, proton planning if applicable), clinical trial dosimetry experience, research or QI contribution, multidisciplinary team integration, teaching/mentoring dosimetry students, complex case complexity. Tone: formal, outcomes- and research-focused. 3 paragraphs.

Version B — Community Cancer Center:
Emphasize: breadth of techniques (3D-CRT through VMAT/SBRT), workflow efficiency and turnaround time, patient-centered care orientation, ability to work as a generalist with high autonomy, cross-training value, QA and safety culture contribution, cost-effective plan quality. Tone: pragmatic, reliability- and service-focused. 3 paragraphs.

Both versions: opening hook specific to that setting; 1-2 quantified achievements; closing with call to action. CMD credential and AAMD membership noted.

Write a LinkedIn headline and 3-paragraph summary in 2 career tracks. My details: [paste name, current role, years post-CMD, institution type, clinical specializations, TPS systems, leadership or QI experience, certifications].

Track 1 — Senior Clinical Dosimetrist:
Headline (120 chars): ["Medical Dosimetrist (CMD) | IMRT/VMAT/SBRT Treatment Planning | [TPS — Eclipse/RayStation] | [City, State]"]
Summary:
P1 — clinical identity and specialization (prostate/H&N/lung/GYN, SBRT volume, brachytherapy if applicable)
P2 — technical depth (TPS proficiency, plan quality metrics, IGRT integration, QA participation)
P3 — professional focus and what you're looking for; AAMD membership; openness to connect with RO teams

Track 2 — Chief Dosimetrist / Dosimetry Supervisor:
Headline: ["Chief Medical Dosimetrist (CMD) | Dosimetry Program Leadership | IMRT/SBRT/Proton | QI & Staff Development | [City]"]
Summary:
P1 — leadership scope (team size, program oversight, workflow design, physicist/physician collaboration)
P2 — operational achievements (turnaround time improvement, peer review compliance rate, ILS submission culture, ACR accreditation contribution)
P3 — vision for dosimetry team excellence; leadership philosophy; open to senior/chief roles

Write a graduate personal statement for a CMD applying to an MS or PhD program. My details: [paste CMD credential date, years of clinical experience, relevant coursework or self-study, research exposure, publications/presentations, faculty or program of interest, why graduate school now].

Choose ONE framing:

Framing A — Treatment Planning Optimization:
Opening: specific clinical moment where manual optimization iteration hit a ceiling — e.g., H&N VMAT plan with 9 critical OARs, 47 optimization iterations, still failing parotid mean constraint while meeting target D95. Research question: how can automated multi-criteria optimization (MCO) or knowledge-based planning (KBP) reduce planning time while maintaining or improving plan quality for complex anatomies? Connect to target faculty's work in automated planning or treatment plan quality benchmarking.

Framing B — AI/ML in Radiation Oncology:
Opening: noticing pattern — the same OAR constraint violations appearing in similar patient anatomy cohorts, suggesting a learnable planning rule. Research interest: deep learning auto-segmentation accuracy in adaptive RT (CBCT-based), reinforcement learning for treatment plan optimization, or outcome prediction from dose-volume features. Clinical dosimetry experience = unique perspective on ground-truth plan quality. Connect to target lab.

Both framings: 3-4 paragraphs. Clinical observation → research gap → your preparation (CMD clinical expertise + technical skills) → program fit. Specific narrative, not a resume recitation.

Write a salary negotiation guide for a CMD. My situation: [paste years post-CMD, institution type, geographic region, specializations — SBRT/proton/brachytherapy, leadership role if applicable, any board certifications beyond CMD].

(1) Market Research — AAMD Salary Survey Benchmarks (approximate; adjust for region/cost-of-living):
   - Community cancer center (general): $80,000–$100,000
   - Comprehensive cancer center / academic medical center: $90,000–$115,000
   - Proton therapy center: $100,000–$130,000+
   - Chief dosimetrist / dosimetry supervisor: $105,000–$130,000+ (5-15% above senior staff)
   - SBRT/SRS specialist (high-volume program): $5,000–$15,000 premium above base typical
   - Brachytherapy specialist (HDR/LDR): additional $5,000–$10,000 premium in programs with high GYN/prostate brachytherapy volume

(2) Premiums to negotiate:
   - SBRT/proton specialty premium: $8,000–$15,000/year above general VMAT base
   - Chief dosimetrist differential: 10-15% above senior staff market rate
   - On-call/after-hours: $300–$800/weekend if coverage required
   - Relocation assistance: $5,000–$15,000 (negotiate separately)

(3) Negotiation script: express enthusiasm; anchor $8,000–$12,000 above target; cite AAMD salary survey and specialty credential value; counter-offer language included.

(4) Non-salary negotiables: CMD CE budget ($2,000–$3,000/year for AAMD Annual Meeting and approved courses); protected planning time (avoid admin overload at senior level); TPS upgrade access; graduate program tuition benefit if MS/PhD is a goal.